← Browse by Condition
Medical Condition
smoldering multiple myeloma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
NCT05597345 Phase 2
Recruiting
Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
Enrollment
15 pts
Location
United States
Sponsor
University of Rochester
NCT06212323
Recruiting
Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
Enrollment
100 pts
Location
United States
Sponsor
University of Utah
NCT06895291
Recruiting
Whole Body MRI in Oncology
Enrollment
1,000 pts
Location
Italy
Sponsor
Istituto Romagnolo per lo Stud...